Chandra Patel

Chandra is Co-founder and Vice President of R&D Operations for GentiBio. Prior to joining GentiBio, Chandra was the Director of Project Management at Casebia Therapeutics focused on the Autoimmune Disease portfolio and supporting HSC and in vivo liver-directed gene editing approaches. Previously, he spent over a decade as a scientist in various research and leadership roles of increasing responsibility at Bayer HealthCare, starting in enzymology and protein engineering and transitioning to non-malignant hematology lab head and research project team lead for multiple projects from discovery to IND stage. He started his career in industry working on next-generation PCR and sequencing technologies at Applied Biosystems. Chandra received his B.S. in Molecular Biology from The University of Texas at Austin and his Ph.D. in Pharmaceutical Sciences from the University of Kentucky.